Memo provides details of new CVS 340B contract pharmacy amendment — please share the memo with your legal team
340B Drug Pricing Program
The 4th U.S. Circuit Court of AppealsMay 28 agreed to rehear challenges to 340B contract pharmacy laws from West Virginia and Maryland.
DEADLINE EXTENDED: Complete 340B survey by June 5.
REMINDER: AHA seeks hospital input on scope of drug company 340B data policy compliance by May 26 deadline.
The Wall Street Journal today published a letter to the editor from AHA General Counsel Chad Golder responding to a May 7 editorial criticizing the 340B Drug Pricing Program. The letter states:
Complete AHA Survey by May 28 on Drug Company 340B Data Policy Compliance
Please contact your representative about a draft bill that could be considered next week.
The AHA today urged Eli Lilly to abandon its 340B Drug Pricing Program claims-data policy and work with the AHA to develop a functional third-party clearinghouse.
AHA urges Lilly to drop 340B claims-data policy, proposes neutral clearinghouse.
The House Committee on Ways and Means released draft bill text in advance of its planned May 20 markup.